# OnCo record pasithea-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/pasithea-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "pasithea-therapeutics" ;
  schema:name "Pasithea Therapeutics"@en ;
  schema:description "Pasithea Therapeutics makes a tablet that blocks MEK, a switch in a growth signalling pathway. It is testing it in people with advanced cancers driven by that pathway and in adults with nerve tumours caused by neurofibromatosis type 1."@en ;
  schema:url <https://onco.cc/companies/pasithea-therapeutics/>, <https://pasithea.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://pasithea.com/>, <https://www.sec.gov/Archives/edgar/data/1841330/000121390026036434/0001213900-26-036434-index.htm>, <https://clinicaltrials.gov/study/NCT06299839>, <https://clinicaltrials.gov/study/NCT06961565> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/mek/> .